Benzinga | Aug 4, 2021 08:02AM EDT

Stephens & Co. Downgrades Avanos Medical to Equal-Weight, Lowers Price Target to $45

Stephens & Co. analyst Chris Cooley downgrades Avanos Medical (NYSE:AVNS) from Overweight to Equal-Weight and lowers the price target from $60 to $45.